Survivin expression in ganglioglioma

Journal of Neuro-Oncology

Volumn 77, Issue 2, 2006, Pages 153-159

  Rousseau, Audrey ^a,c   Kujas, Michèle ^a   Bergemer Fouquet, Anne Marie ^b   Effenterre, Rémy ^a   Hauw, Jean Jacques ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CHU BRETONNEAU   (France)

^c Molecular Neurogenetics Unit   (United States)

Author keywords

Apoptosis; Brain tumor; Central nervous system; Ganglioglioma; Glioneuronal tumor; Immunohistochemistry; Prognosis; Survivin

Indexed keywords

SURVIVIN; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; FOLLOW UP; GLIA CELL; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; BIOSYNTHESIS; BRAIN TUMOR; FEMALE; INFANT; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; FEMALE; GANGLIOGLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33747815119     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9033-9     Document Type: Article

References (44)

1. Lantos PL, Louis DN, Rosenblum MK, Kleihues P: Tumours of the nervous system In: Graham DI, Lantos PL, (eds) Greenfield's Neuropathology. Arnold, London 2002, pp. 767-980
2. Nelson JS, Bruner JM, Wiestler OD, Vandenberg SR, 2000 Ganglioglioma and gangliocytoma In: Kleihues P, Cavenee WK, (eds) Pathology and Genetics of Tumours of the Nervous System. World Health Organization Classification of TumoursIARC, Lyon, 96-98
3. Im SH, Chung CK, Cho BK, Lee SK, 2002 Supratentorial ganglioglioma and epilepsy: Postoperative seizure outcome J Neurooncol 57: 59-66
4. Blümcke I, Wiestler OD, 2002 Gangliogliomas: An intriguing tumor entity associated with focal epilepsies J Neuropathol Exp Neurol 61:575-584
5. Prayson RA, Khajavi K, Comair YG, 1995 Cortical architectural abnormalities and MIB1 immunoreactivity in gangliogliomas: A study of 60 patients with intracranial tumors J Neuropathol Exp Neurol 54:513-520
6. Wolf HK, Müller MB, Spänle M, Zentner J, Schramm J, Wiestler OD, 1994 Gangliogliomas: A detailed histopathological and immunohistochemical analysis of 61 cases Acta Neuropathol 88: 166-173
7. Im SH, Chung CK, Cho BK, Wang KC, Yu IK, Song IC, Cheon GJ, Lee DS, Kim NR, Chi JG, 2002 Intracranial ganglioglioma: Preoperative characteristics and oncologic outcome after surgery J Neurooncol 59: 173-183
8. Zentner J, Wolf HK, Ostertun B, Hufnagel A, Campos MG, Solymosi L, Schramm J, 1994 Gangliogliomas: Clinical, radiological, and histopathological findings in 51 patients J Neurol Neurosurg Psychiatry 57: 1497-1502
9. Prayson RA, Estes ML, Morris HH, 1993 Coexistence of neoplasia and cortical dysplasia in patients presenting with seizures Epilepsia 34: 609-615
10. Mickle JP, 1992 Ganglioglioma in children: A review of 32 cases at the University of FloridaPediatr Neurosurg 18: 310-314
11. Zhu JJ, Leon SP, Folkerth RD, Guo SZ, Wu JK, Black PM, 1997 Evidence for clonal origin of neoplastic neuronal and glial cells in gangliogliomas Am J Pathol 151: 565-571
12. Hakim R, Loeffler JS, Anthony DC, Black PM, 1997 Gangliogliomas in adults Cancer 79: 127-131
13. Selch M, Goy BW, Lee SP, El-Sadin S, Kincaid P, Park SH, Withers HR, 1998 Gangliogliomas. Experience with 34 patients and review of the literature Am J Clin Oncol 21: 557-564
14. Hirose T, Scheithauer BW, Gerber HA, Altermatt HJ, Vandenberg SR, 1997 Ganglioglioma. An ultrastructural and immunohistochemical studyCancer 79: 989-1003
15. Rumana CS, Valadka AB, 1998 Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas Neurosurg 42: 1038-1043
16. Sasaki A, Hirato J, Nakazato Y, Tamura M, Kadowaki H, 1996 Recurrent anaplastic ganglioglioma: Pathological characterization of tumor cells J Neurosurg 84: 1055-1059
17. Danjoux M, Sabatier J, Uro-Coste E, Roche H, Delisle M-B, 2001 Gangliogliome anaplasique temporal avec métastases médullaires Ann Pathol 21: 55-58
18. Hayashi Y, Iwato M, Hasegawa M, Tachibana O, von Deimling A, Yamashita J, 2001 Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: A molecular genetic analysis J Neurosurg 95: 138-142
19. Miller DC, Lang FF, Epstein FJ, 1993 Central nervous system gangliogliomas. Part 1: Pathology J Neurosurg 79: 859-866
20. Wacker MR, Cogen PH, Etzell E, Daneshvar L, Davis RL, Prados MD, 1992 Diffuse leptomeningeal involvement by a ganglioglioma in a child J Neurosurg 77: 302-306
21. Lang FF, Epstein FJ, Ransohoff J, Allen JC, Wisoff J, Abbott IR, Miller DC, 1993 Central nervous system gangliogliomas. Part 2: Clinical outcome J Neurosurg 79: 867-873
22. Luyken C, Blümcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J, 2004 Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years Cancer 101: 146-155
23. Monzo M, Rosell R, Felip E, Astudillo J, Sanchez J, Maestre J, Martin C, Font A, Barnadas A, Abad A, 1999 A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers J Clin Oncol 17: 2100-2104
24. Sarela A, Macadam R, Farmery S, Makham A, Guillou P, 2000 Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma Gut 46: 645-650
25. Sarela AI, Scott N, Ramsdale J, Markham AF, Guillou PJ, 2001 Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas Ann Surg Oncol 8: 305-310
26. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N, 2000 Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 6: 127-134
27. Fangusaro JR, Jiang Y, Holloway MP, Caldas H, Singh V, Boué DR, Hayes J, Altura RA, 2005 Survivin, Survivin-2B, and Survivin-deltaEx3 expression in medulloblastoma: Biologic markers of tumour morphology and clinical outcome Br J Cancer 1-7
28. Kajiwara Y, Yamasaki F, Hama S, Yahara K, Yoshioka H, Sugiyama K, Arita K, Kurisu K, 2003 Expression of survivin in astrocytic tumors. Correlation with malignant grade and prognosis Cancer 97: 1077-1083
29. Chakravarti A, Noll E, Black P McL, Finkelstein DF, Dianne M, Dyson NJ, Loeffler JS, 2002 Quantitatively determined survivin expression levels are of prognostic value in human gliomas J Clin Oncol 20: 1063-1068
30. Caldas H, Jiang Y, Holloway MP, Fangusaro J, Mahotka C, Altura RA, Conway EM, 2005 Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 1-14
31. Ambrosini G, Adida C, Altieri DC, 1997 A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med 3: 917-921
32. Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC, 1998 Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation Am J Pathol 152: 43-49
33. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Brière J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ, 2000 Prognostic significance of survivin expression in diffuse large B-cell lymphomas Blood 96: 1921-1925
34. Invernizzi R, Travaglino E, Lunghi M, Klersy C, Bernasconi P, Cazzola M, Ascari E, 2004 Survivin expression in acute leukemias and myelodysplastic syndromes Leuk Lymphoma 45: 2229-2237
35. Uematsu M, Ohsawa I, Aokage T, Nishimaki K, Matsumoto K, Takahashi H, Asoh S, Teramoto A, Ohta S, 2005 Prognostic significance of the immunohistochemical index of survivin in glioma: A comparative study with the MIB-1 index J Neurooncol 72: 231-238
36. Chakravarti A, Zhai GG, Zhang M, Malhotra R, Latham DE, Delaney MA, Robe P, Nestler U, Song Q, Loeffler J, 2004 Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms Oncogene 23: 7494-7506
37. Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D, Watanabe N, 2000 Survivin as a radioresistance factor in pancreatic cancer Jpn J Cancer Res 91: 1204-1209
38. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC, 1998 IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs Cancer Res 58: 5315-5320
39. Li F, 2004 Role of survivin and its slice variants in tumorigenesis Br J Cancer 1-5
40. Hassounah M, Lach B, Allam A, Al-Khalaf H, Siddiqui Y, Pangue-Cruz N, Al-Omeir A, Al-Ahdal MN, Aboussekhra A, 2005 Benign tumors from the human nervous system express high levels of survivin and are resistant to spontaneous and radiation-induced apoptosis J Neurooncol 72: 203-208
41. Julien T, Frankel B, Longo S, Kyle M, Gibson S, Shillitoe E, Ryken T, 2000 Antisense-mediated inhibition of the bcl-2 gene induces apoptosis in human malignant glioma Surg Neurol 53: 360-368
42. O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, Li F, Nath AK, Pober JS, Altieri DC, 2000 Control of apoptosis during angiogenesis by survivin expression in endothelial cells Am J Pathol 156: 393-398
43. Mesri M, Morales-Ruiz M, Ackermann EJ, Bennett CF, Pober JS, Sessa WC, Altieri DC, 2001 Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am J Pathol 158: 1757-1765
44. Altieri DC, 2003 Validating survivin as a cancer therapeutic target Nat Rev Cancer 3: 46-54